The antiviral agent cidofovir [(S)-1-(3-hydroxy-2-phosphonyl- methoxypropyl) cytosine] has pronounced activity against nasopharyngeal carcinoma grown in nude mice

Cancer Research

Volumn 58, Issue 3, 1998, Pages 384-388

  Neyts, Johan ^a,b   Sadler, Robert ^a   De Clercq, Erik ^b   Raab Traub, Nancy ^a   Pagano, Joseph S ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CIDOFOVIR; GANCICLOVIR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GRAFT; CANCER GROWTH; CANCER INHIBITION; CANCER REGRESSION; CONTROLLED STUDY; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRATUMORAL DRUG ADMINISTRATION; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; VIRUS CELL TRANSFORMATION; XENOGRAFT;

ADOLESCENT; ANIMALS; ANTIVIRAL AGENTS; APOPTOSIS; CARCINOMA; CYTOSINE; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; GANCICLOVIR; GENES, P53; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; INJECTIONS, INTRALESIONAL; MICE; MICE, NUDE; NASOPHARYNGEAL NEOPLASMS; NEOPLASM TRANSPLANTATION; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHONIC ACIDS; TUMOR VIRUS INFECTIONS;

EID: 0032005187     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. De Clercq, E. Broad spectrum anti-DNA virus and anti-retrovirus activity of phosphonyl-methoxyalkylpurines and -pyrimidines. Biochem Pharmacol., 42: 963-972, 1991.
2. Snoeck, R., Andrei, G., Gerard, M. M., Silverman, A., Hedderman, A., Balzarini, J., Sadzot-Delvaux, C. Tricot, G., Clumeck, N., and De Clercq, E. Successful treatment of progressive mucocutaneous infection due to acyclovir-and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine (HPMPC). Clin. Infect. Dis., 18: 570-578, 1994.
3. Gordon, Y. J., Naesens, L., De Clercq, E., Maudgal, P. C., and Veckeneer, M, Treatment of adenoviral conjunctivitis with topical cidofovir. Cornea, 15: 546, 1996.
4. Lalezari, J. P., Stagg, R. J., Kuppermann, B. D., Holland, G. R., Kramer, F., Ives, D. V., Youle, M., Robinson, M. R., Drew, W. L., and Jaffe, H. R. Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS: a randomized, controlled trial. Ann. Intern. Med., 126: 257-263, 1997.
5. Lin, J. C., De Clercq, E., and Pagano, J. S. Inhibitory effects of acyclic nucleoside phosphonate analogs, including (S)-1(3 hydroxyphosphonylmethoxypropyl) cytosine, on Epstein-Barr virus replication. Antimicrob. Agents Chemother, 35: 2440-2443, 1991.
6. Gilligan, K., Rajadurai, P., Resnick, L., and Raab-Traub, N. Epstein-Barr virus small RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia. Proc. Natl. Acad. Sci. USA. 87: 8790-8794, 1990.
7. Van Cutsem, E., Snoeck, R., Van Ranst, M., Fiten, P., Opdenakker, G., Geboes, K., Janssens, J., Rutgeers, P., Vantrappen, G., and De Clercq, E. Successful treatment of a squamous papilloma of the hypopharynx-oesophagus by local injections of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine. J. Med. Virol., 45: 230-235, 1995.
8. Snoeck, R., Van Ranst, M., Andrei, G., De Clercq, E., De Wit, S., Poncin, M., and Clumeck, N. Treatment of anogenital papillomavirus infections with an acyclic nucleoside phosphonate analogue. N. Engl. J. Med., 333: 943-944, 1995.
9. Raab-Traub, N. Epstein-Barr virus and nasopharyngeal carcinoma. Semin Cancer Biol., 3: 297-307, 1992.
10. Pathmanathan, R., Prasad, U., Gangatharan, C., Sadler, R., Flynn, K., and Raab-Traub, N. Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Am. J. Pathol., 146: 1355-1367, 1995.
11. Teo, P., Leung, T. W., Chan, A. T., Yu, P., Lee, W. Y., Leung, S. F., Kwan, W. H., and Johnson, P. A retrospective sludy of the use of cisplatinum-5-fluorouracil neoadjuvant chemotherapy in cervical-node-positive nasopharyngeal carcinoma (NPC). Eur. J. Cancer. Part B, Oral Oncol., 31B: 373-379, 1995.
12. Dugan, M., Choy, D., Ngai, A., Sham, J., Choi, P., Shiu, W., Leung, T., Teo, P., Prasad, U., Lee, S., Villalon, A., Tan, B., Chen, K. Y., Hsu, M. M., Vootitrux, V., Dy, E., Hoffman, A., Reisman, A., and Neal, J. Multicenter Phase II trial of mitoxantrone in patients with advanced nasopharyngeal carcinoma in Southeast Asia: an Asian-Oceanian Clinical Oncology Association Group Study. J. Clin. Oncol., 11: 70-76, 1993.
13. Busson, P., Ganem, G., Flores, P., Mugneret, F., Clausse, B., Caillou, B., Brahan, K., Wakasugi, H., Lipinski, M., and Tursz, T. Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas. Int. J. Cancer, 42: 599-606, 1988.
14. Chang, K. L., Chen, Y. Y., Shibata, D., and Weiss, L. M. Detection of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissue. Diagn. Mol. Pathol., 1: 246-255, 1992.
15. Pagano, J. S. Epstein-Barr virus. In: D. J. Jeffries and E. De Clercq (eds.), Antiviral Chemotherapy, pp. 155-195. New York. John Wiley & Sons Ltd., 1995.
16. Effert, P., Abdel-Hamid, M., McCoy, R., Flynn, K., Busson, P., Zhang, Q., Tursz, T., Liu, E., and Raab-Traub, N. Alterations of the p53 gene in nasopharyngeal carcinoma J. Virol., 66: 3768-3775, 1992.
17. Neyts, J., and De Clercq, E. Mechanism of action of acyclic nucleoside phosphorates against herpes virus replication. Biochem. Pharmacol., 47: 39-41, 1994.
18. Xiong, X., Smith, J. L., Kim, C., Huang, E., and Chen, M. S. Kinetic analysis of the interaction of cidofovir diphosphate with human cytomegalovirus DNA polymerase. Biochem. Pharmacol., 51: 1563-1567, 1996.
19. Wang, C. Y., Mayo, M. W., and Baldwin, A. S., Jr. TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science (Washington) 274: 784-787, 1996.
20. Snoeck, R., Sakuma, T., De Clercq, E., Rosenberg, I., and Holý, A. (S)-1-(3-Hydroxy-2-phosphonylmethoxypropyl) cytosine, a potent and selective inhibitor of human cytomegalovirus replication. Antimicrob. Agents Chemother., 32: 1839-1844, 1988.
21. Jaffrezou, J. P., Levade, T., Bettaieb, A., Andrieu, N., Bezombes, C., Maestre, N., Vermeersch, S., Rousse, A., and Laurent, G. Daunorubicin-induced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysis. EMBO J., 15: 2417-2424, 1996.
22. Huang, P., and Plunkett, W. Induction of apoptosis by gemcitabine. Semin. Oncol., 22: 19-25, 1995.
23. Xiong, X., Smith, J. L., and Chen, M. S. Effect of incorporation of cidofovir into DNA by human cytomegalovirus DNA polymerase on DNA elongation. Antimicrob. Agents Chemother., 41: 594-599, 1997.
24. Wachman, M., Pettey, B. G., Cundy, K. C., Jaffe, H. S., Fisher, P. E., Pastelak, A., and Lietman, P. Pharmacokinetics, safety and bioavailability of HPMPC (cidofovir) in human immunodeficiency virus-infected subjects. Antiviral Res., 29: 153-161, 1996.
25. Fries, K. L., Miller, W. E., and Raab-Traub, N. Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 game J. Virol., 70: 8653-8659, 1996.
26. Huschtscha, L. I., Bartier, W. A., Ross, C. E., and Tattersall, M. H. Characteristics of cancer cell death after exposure to cytotoxic drugs in vitro. Br. J. Cancer, 73: 54-60, 1996.
27. Bischofberger, N., Hitchcock, N. J. M., Chen, M. S., Barkhimer, D. B., Cundy, K. C., Kent, K. M., Lacy, S. A., Lee, W. A., Li, Z. H., Mendel, D., Smee, D. F., and Smith, J. L. 1-[(S)-2-Hydroxy-2-oxo-1.4.2.-dioxaphosphorinan-5-yl) methyl] cytosine, an intracellular prodrug for (S)-1(3-hydroxy-2-phosphonylmethoxypropyl) cytosine with improved therapeutic index in vivo. Antimicrob. Agents Chemother., 38: 2387-2391, 1994.
28. Mendel, D. B., Cihlar, T., Moon, K., and Chen, M. S. Conversion of 1-[(S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-y1) methyl] cytosine to cidofovir by an intracellular cyclic CMP phosphodiesterase. Antimicrob. Agents Chemother., 41: 641-646, 1997.